{
  "data": {
    "indicator": {
      "slug": "medicines-with-new-active-substances-recommended-for-marketing-authorisation",
      "name": "Medicines with new active substances recommended for marketing authorisation",
      "definition": "Number of medicines containing a new active substance not previously authorised recommended for marketing authorisation.",
      "unit": "count",
      "scale": "1",
      "default_unit": "count",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "count",
    "region": {
      "code": "EU",
      "name": "European Union",
      "type": "bloc"
    },
    "points": [
      {
        "period_start": "2022-01-01",
        "period_label": "2022",
        "value": 42,
        "scale": "1",
        "unit": "count",
        "value_type": "actual",
        "statistic_id": "stat_M6S01C976QWYFKEGN8SMWPT6AJ",
        "url": "https://statorigin.org/stat/stat_M6S01C976QWYFKEGN8SMWPT6AJ",
        "source_org": "EMA",
        "source": {
          "org": "European Medicines Agency",
          "org_short_name": "EMA",
          "document_title": "Human medicines: highlights of 2022",
          "document_url": "https://www.ema.europa.eu/en/news/human-medicines-highlights-2022",
          "locator": "Update as of 3 March 2026",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "EU"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}